P01.019 Blood derived exosomal hTERT mRNA in glioblastoma: A potential circulating biomarker
Clicks: 107
ID: 273962
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
107 views
18 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #38 of 43 articles by views in Neuro-Oncology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractBackground. Primary glioblastoma multiforme (GBM) have a high proportion (~80%) of TERT-expressing tumors, indicating that this is the primary mechanism
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (19 words).
Try re-searching for a better abstract.
| Reference Key |
o2018neuro-oncologyp01.019
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Uziel, O;Beery, E;Lahav, M;Abu Shkara, R;Yust-Katz, S;Amiel, A;Kanner, A A;Laviv, Y;Ben Zvi, I;Siegal, T; |
| Journal | Neuro-Oncology |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.